Close
May 23, 2024 08:15AM
May 23, 2024 07:31AM
May 23, 2024 07:05AM
May 23, 2024 07:00AM
May 22, 2024 04:55PM
May 22, 2024 09:03AM
May 22, 2024 08:15AM Coya Therapeutics (COYA) Announces Completion of Controlled Phase 2 Study of Low Dose Interleukin-2 (LD IL-2) in Patients with Alzheimer’s Disease
May 22, 2024 08:05AM
May 22, 2024 08:02AM
May 22, 2024 08:01AM
May 22, 2024 07:37AM
May 22, 2024 07:05AM
May 22, 2024 07:02AM
May 22, 2024 07:01AM Cartesian Therapeutics (RNAC) Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis
May 21, 2024 05:00PM
May 21, 2024 04:07PM
May 21, 2024 02:30PM
May 21, 2024 09:27AM
May 21, 2024 08:45AM
May 21, 2024 08:45AM
May 21, 2024 08:35AM GRI Bio, Inc (GRI) Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators
May 21, 2024 08:30AM
May 21, 2024 08:30AM
May 21, 2024 08:06AM
May 21, 2024 08:04AM
May 21, 2024 08:02AM
May 21, 2024 08:01AM
May 21, 2024 08:01AM Lipella Pharmaceuticals (LIPO): Following Guidance from FDA in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b
May 21, 2024 07:30AM
May 21, 2024 07:16AM
May 21, 2024 07:15AM
May 21, 2024 07:01AM
May 21, 2024 06:59AM
May 20, 2024 04:28PM
May 20, 2024 04:08PM Larimar Therapeutics (LRMR) Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program
May 20, 2024 02:30PM
May 20, 2024 09:32AM
May 20, 2024 09:25AM
May 20, 2024 08:45AM
May 20, 2024 08:31AM
May 20, 2024 08:03AM
May 20, 2024 08:02AM Mira Pharma (MIRA) Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, a Differentiated Oral Ketamine Analog
May 20, 2024 07:14AM
May 20, 2024 07:01AM
May 20, 2024 06:50AM
May 20, 2024 06:31AM
May 20, 2024 06:02AM
May 20, 2024 06:01AM
May 20, 2024 06:00AM Esperion (ESPR) and Otsuka Report Bempedoic Acid Met Primary Endpoint in Phase 3 Trial
May 20, 2024 05:54AM

67,135 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving FDA reports.